Robbie Williams warns GLP-1 drugs may cause vision loss. What does this mean for food & beverage innovation and natural ...

The Danish drugmaker said it's cutting the price of Wegovy and Ozempic from $499 to $349 per month for some customers who buy ...

The maker of the weight-loss and diabetes drugs Wegovy and Ozempic has cut the prices for most versions of these blockbuster ...

Novo Nordisk has started selling its weight-loss drug Wegovy for $349 a month to cash payers, implementing the price cut months earlier than planned under its agr ...

LifeMD expands access to Wegovy and Ozempic at the lowest cash-pay pricing, reinforcing its commitment to patient affordability and high-quality care ...

The cash price for popular weight-loss medication Wegovy is dropping by 30% in U.S. on Monday, according to Novo Nordisk.

GoodRx Holdings Inc (NASDAQ:GDRX) stock edged up 1.7% in premarket trading Monday after the medication savings platform announced two major initiatives to make GLP-1 weight loss medications more ...

Facing increased competition in the weight loss market and intense pressure from President Donald Trump, Novo Nordisk ...

Arizona lawmakers and health experts are considering extending state Medicaid coverage to include treatment for obesity.

Novo also has started a temporary offer of $199 a month for the first two months of low doses of Wegovy and the drug’s counterpart for diabetes, Ozempic. The new pricing will be available at ...

Novo Nordisk said on Monday it has begun selling its popular weight-loss drug Wegovy for $349 a month to cash payers, months ...